In this webinar, experts will take a deep dive into Delphi panel methods, their implementation, and pharmaceutical industry insights on the panels' uses and outcomes.
For over 15 years, PHAR has conducted RAND/UCLA modified Delphi panels, a systematic and validated way to obtain consensus among clinicians and other experts, such as patient advocates. The speakers plan to broadly present different methods for gaining consensus, including the different Delphi panel approaches that exist, the history of the method’s use, the behavioral science behind why these panels work, how these panels are conducted (both in person and virtually), and the outcomes of the panels.
Alongside PHAR President Dr. Michael Broder, two senior researchers from the pharmaceutical industry will provide their perspective on leading these panels (including why sometimes it’s recommended they are blinded to all aspects), their experience participating in the discussions, and how they have used the results.
Key Topics Include:
- Overview of the different ways to obtain consensus from expert clinicians
- The broad steps involved in conducting a RAND/UCLA modified Delphi panel method
- The possible outcomes of such a panel
- Benefits and challenges of this method
- Categories: Real World Evidence
- Tags: behavioral science, clinical trials, Delphi panel, expert panels, pharmaceutical, pharmacology, real world evidence
Partnership for Health Analytic Research (PHAR)
Executive Director, Medical Evidence Generation
Health Economics and Outcomes Research